Results 121 to 130 of about 11,408,388 (316)

Guiding principles for health equity in oncology: insights from patient organizations from the Middle East and Africa

Frontiers in Health Services
This paper explores the role of patient advocacy in fostering patient-centered care (PCC), empowerment, and equitable access to healthcare in the Middle East and Africa (MEA) region.
Sawsan Al-Madhi, Lauren Pretorius, Emad Shash, Emad Shash, Belma Kurdoglu, Ahmad Rabea, Ahmad Rabea, Ahmad Rabea, Atlal Abusanad, Hani Nassar, Hamida Kettab, Benda Kithaka, Khaled Abdel Aziz   +12 more
doaj   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

Cancer Trends: Primary Liver Cancer

, 2016
During 2012-2014, a little over half (58%) of all primary liver cancers were histologically confirmed, 37% were diagnosed radiologically only via x-ray, MRI/CT scan etc. and 5% did not have a method of diagnosis specified.
National Cancer Registry Ireland (NCRI)
core  

Diagnosing cancer in an emergency: Patterns of emergency presentation of cancer in Ireland 2002–2015 [PDF]

, 2018
Emergency presentation with cancer can result from lack of awareness of symptoms in patients and is generally associated with more advanced stage, limited treatment options and poorer survival outcomes.
National Cancer Registry Ireland (NCRI), Irish Cancer Society   +1 more
core  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

ATNEC – Patient Experience Sub-Study (IRSCTN: 36585784): What Patients Think About Taking Part In Breast Cancer Treatment De-Escalation Trials?

Breast, 2023
Janet A. Dunn, Sophie Gasson, Sophie Nicholls, Jan Rose, Helen Teresa Edwards, Andrea Marshall, Natalie Hammonds, Beatrix Elsberger, Amit Goyal   +8 more
doaj   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Laddering Through Pedigrees: Family History of Malignancies in Primary Breast Cancer Patients [PDF]

A family history (FH) of breast cancer (BC) is a long recognized risk factor for developing the disease. Also, there ‍have been some reports of links between an FH and some other malignancies (mostly uterus, ovary, and prostate ‍cancers), and an ...
جعفری مجرد, الهام, حسینی اصل, سید سعید, جاویدروزی, مازیار, مهدی پور, پروین, عطری, مرتضی   +4 more
core  

Patients With Cancer

Clinical and Applied Thrombosis/Hemostasis, 2013
A. Nicolaides, J. Fareed, A. K. Kakkar, A. J. Comerota, S. Z. Goldhaber, R. Hull, K. Myers, M. Samama, J. Fletcher, E. Kalodiki, D. Bergqvist, J. Bonnar, J. A. Caprini, C. Carter, J. Conard, B. Eklof, I. Elalamy, G. Gerotziafas, G. Geroulakos, A. Giannoukas, I. Greer, M. Griffin, S. Kakkos, M. R. Lassen, G. D. O. Lowe, A. Markel, P. Prandoni, G. Raskob, A. C. Spyropoulos, A. G. Turpie, J. M. Walenga, D. Warwick   +31 more
openaire   +2 more sources

Prehabilitation in cancer patients

Nutrición Hospitalaria
Prehabilitation in oncology is a strategy aimed at improving the patient's functional, nutritional, and psychological status prior to cancer treatment, especially surgery. Growing evidence supports its effectiveness in improving postoperative outcomes and tolerance to treatments such as chemotherapy and radiotherapy. This review outlines the conceptual
Ovidio, Hernando-Requejo, Hortensia, García de Quinto   +1 more
openaire   +2 more sources